Bioventus Inc. (BVS) balance sheet
BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Nov 2, 2026Score 13/3036% below fair value
$9.88−0.07 (-0.70%)
Close on Nov 20, 2026Market cap $830.83MP/E 12.8Yield –
Bioventus Inc. balance sheet
Ratios
Latest available, balances at Jun 27, 2026
Profitability, TTM
- Gross margin
- 68.7%
- Operating margin
- 10.0%
- Net margin
- 9.4%
- Return on equity, FY2025
- 13.7%
Financial strength
- Current ratio
- 1.69
- Debt to equity
- 1.09
- Debt to assets
- 36.9%
- Cash to current liabilities
- 19.3%
Valuation
- P/E ratio
- 12.8
- Price to sales
- 1.43
- Price to book
- 3.64
- Dividend yield
- –
See a number that looks wrong?